LMR Plus (lidocaine) NDC 72835-501

NDC codes

FDA NDC Directory

Product NDC (as listed)72835-501Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72835-0501Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72835-501-02	72835050102	1 KIT in 1 CARTON (72835-501-02) * 30 POUCH in 1 CARTON (65162-791-08) / 1 PATCH in 1 POUCH (65162-791-04) * 89 g in 1 BOTTLE, PLASTIC (72667-073-01)Marketed from Jun 3, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): LMR Plus
Generic name (nonproprietary): lidocaine
Dosage form: Kit
Labeler: V2 Pharma, LLC
Product type: Prescription drug
Marketing category: Unapproved drug (other)
Marketing start: Jun 3, 2019
Listing expires: Dec 31, 2026
Identifiers: Product ID 72835-501_6abaac8a-d108-45c6-aefd-0f9209dcdb76SPL ID 6abaac8a-d108-45c6-aefd-0f9209dcdb76SPL set ID 7c84e443-67fe-40b5-b721-86e9e7c4d490RxCUI 415976, 1745091UPC 0365162791044, 0685757118491

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N472835050102 followed by a unit qualifier and the quantity

Package 72835-0501-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 30, 2024.

Indications (excerpt from the label)

INDICATION AND USAGE Lidocaine patch 5% is indicated for relief of pain associated with post-herpetic neuralgia. It should be applied only to intact skin .

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)